FLNB and hereditary leiomyomatosis and renal cell cancer: The presence of fumarate in the urine is not unexpected considering the high levels of fumarate detected in Fh1-deficient cells and tumors [4,5,10], but this is the first report which demonstrates the potential use of urine fumarate as a biomarker for early detection of renal cancer formation in HLRCC patients.